Brain Bionics - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509249712

Publication Date:

September 11, 2024

Pages:

135

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Brain bionics, also known as brain-computer interfaces (BCIs) or neuroprosthetics, are devices that establish direct communication between the brain and external systems or computers. They allow individuals with neurological disorders or disabilities to control devices or interact with the environment using their brain activity.
The global market for Brain Bionics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The brain bionics market is driven by the increasing prevalence of neurological disorders and disabilities, as well as the growing demand for assistive technologies. Technological advancements in brain-computer interface technology and neural engineering have significantly impacted the market's growth.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Brain Bionics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Brain Bionics by region & country, by Type, and by Application.
The Brain Bionics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brain Bionics.
麻豆原创 Segmentation
By Company
Abiomed Inc.
Activelink
Advanced Bionics
Alterg
Axosuits
Bae Systems
Bionx Medical Technologies
B-Temia
Bana Teknoloji
Bionik Laboratories
Bioservo Technologies
Carmat
Cleveland Fes Center
COAPT
Cochlear
Cyberdyne
Segment by Type:
Deep Brain Stimulators
Spinal Cord Stimulators
Vagus Nerves Stimulators
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Brain Bionics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Brain Bionics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Brain Bionics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Brain Bionics Product Introduction
1.2 Global Brain Bionics 麻豆原创 Size Forecast
1.3 Brain Bionics 麻豆原创 Trends & Drivers
1.3.1 Brain Bionics Industry Trends
1.3.2 Brain Bionics 麻豆原创 Drivers & Opportunity
1.3.3 Brain Bionics 麻豆原创 Challenges
1.3.4 Brain Bionics 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Brain Bionics Players Revenue Ranking (2023)
2.2 Global Brain Bionics Revenue by Company (2019-2024)
2.3 Key Companies Brain Bionics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Brain Bionics Product Offered
2.5 Key Companies Time to Begin Mass Production of Brain Bionics
2.6 Brain Bionics 麻豆原创 Competitive Analysis
2.6.1 Brain Bionics 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Brain Bionics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Bionics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Deep Brain Stimulators
3.1.2 Spinal Cord Stimulators
3.1.3 Vagus Nerves Stimulators
3.2 Global Brain Bionics Sales Value by Type
3.2.1 Global Brain Bionics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Brain Bionics Sales Value, by Type (2019-2030)
3.2.3 Global Brain Bionics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Brain Bionics Sales Value by Application
4.2.1 Global Brain Bionics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Brain Bionics Sales Value, by Application (2019-2030)
4.2.3 Global Brain Bionics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Brain Bionics Sales Value by Region
5.1.1 Global Brain Bionics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Brain Bionics Sales Value by Region (2019-2024)
5.1.3 Global Brain Bionics Sales Value by Region (2025-2030)
5.1.4 Global Brain Bionics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Brain Bionics Sales Value, 2019-2030
5.2.2 North America Brain Bionics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Brain Bionics Sales Value, 2019-2030
5.3.2 Europe Brain Bionics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Brain Bionics Sales Value, 2019-2030
5.4.2 Asia Pacific Brain Bionics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Brain Bionics Sales Value, 2019-2030
5.5.2 South America Brain Bionics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Brain Bionics Sales Value, 2019-2030
5.6.2 Middle East & Africa Brain Bionics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Brain Bionics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Brain Bionics Sales Value
6.3 United States
6.3.1 United States Brain Bionics Sales Value, 2019-2030
6.3.2 United States Brain Bionics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Brain Bionics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Brain Bionics Sales Value, 2019-2030
6.4.2 Europe Brain Bionics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Brain Bionics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Brain Bionics Sales Value, 2019-2030
6.5.2 China Brain Bionics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Brain Bionics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Brain Bionics Sales Value, 2019-2030
6.6.2 Japan Brain Bionics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Brain Bionics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Brain Bionics Sales Value, 2019-2030
6.7.2 South Korea Brain Bionics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Brain Bionics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Brain Bionics Sales Value, 2019-2030
6.8.2 Southeast Asia Brain Bionics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Brain Bionics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Brain Bionics Sales Value, 2019-2030
6.9.2 India Brain Bionics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Brain Bionics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abiomed Inc.
7.1.1 Abiomed Inc. Profile
7.1.2 Abiomed Inc. Main Business
7.1.3 Abiomed Inc. Brain Bionics Products, Services and Solutions
7.1.4 Abiomed Inc. Brain Bionics Revenue (US$ Million) & (2019-2024)
7.1.5 Abiomed Inc. Recent Developments
7.2 Activelink
7.2.1 Activelink Profile
7.2.2 Activelink Main Business
7.2.3 Activelink Brain Bionics Products, Services and Solutions
7.2.4 Activelink Brain Bionics Revenue (US$ Million) & (2019-2024)
7.2.5 Activelink Recent Developments
7.3 Advanced Bionics
7.3.1 Advanced Bionics Profile
7.3.2 Advanced Bionics Main Business
7.3.3 Advanced Bionics Brain Bionics Products, Services and Solutions
7.3.4 Advanced Bionics Brain Bionics Revenue (US$ Million) & (2019-2024)
7.3.5 Alterg Recent Developments
7.4 Alterg
7.4.1 Alterg Profile
7.4.2 Alterg Main Business
7.4.3 Alterg Brain Bionics Products, Services and Solutions
7.4.4 Alterg Brain Bionics Revenue (US$ Million) & (2019-2024)
7.4.5 Alterg Recent Developments
7.5 Axosuits
7.5.1 Axosuits Profile
7.5.2 Axosuits Main Business
7.5.3 Axosuits Brain Bionics Products, Services and Solutions
7.5.4 Axosuits Brain Bionics Revenue (US$ Million) & (2019-2024)
7.5.5 Axosuits Recent Developments
7.6 Bae Systems
7.6.1 Bae Systems Profile
7.6.2 Bae Systems Main Business
7.6.3 Bae Systems Brain Bionics Products, Services and Solutions
7.6.4 Bae Systems Brain Bionics Revenue (US$ Million) & (2019-2024)
7.6.5 Bae Systems Recent Developments
7.7 Bionx Medical Technologies
7.7.1 Bionx Medical Technologies Profile
7.7.2 Bionx Medical Technologies Main Business
7.7.3 Bionx Medical Technologies Brain Bionics Products, Services and Solutions
7.7.4 Bionx Medical Technologies Brain Bionics Revenue (US$ Million) & (2019-2024)
7.7.5 Bionx Medical Technologies Recent Developments
7.8 B-Temia
7.8.1 B-Temia Profile
7.8.2 B-Temia Main Business
7.8.3 B-Temia Brain Bionics Products, Services and Solutions
7.8.4 B-Temia Brain Bionics Revenue (US$ Million) & (2019-2024)
7.8.5 B-Temia Recent Developments
7.9 Bana Teknoloji
7.9.1 Bana Teknoloji Profile
7.9.2 Bana Teknoloji Main Business
7.9.3 Bana Teknoloji Brain Bionics Products, Services and Solutions
7.9.4 Bana Teknoloji Brain Bionics Revenue (US$ Million) & (2019-2024)
7.9.5 Bana Teknoloji Recent Developments
7.10 Bionik Laboratories
7.10.1 Bionik Laboratories Profile
7.10.2 Bionik Laboratories Main Business
7.10.3 Bionik Laboratories Brain Bionics Products, Services and Solutions
7.10.4 Bionik Laboratories Brain Bionics Revenue (US$ Million) & (2019-2024)
7.10.5 Bionik Laboratories Recent Developments
7.11 Bioservo Technologies
7.11.1 Bioservo Technologies Profile
7.11.2 Bioservo Technologies Main Business
7.11.3 Bioservo Technologies Brain Bionics Products, Services and Solutions
7.11.4 Bioservo Technologies Brain Bionics Revenue (US$ Million) & (2019-2024)
7.11.5 Bioservo Technologies Recent Developments
7.12 Carmat
7.12.1 Carmat Profile
7.12.2 Carmat Main Business
7.12.3 Carmat Brain Bionics Products, Services and Solutions
7.12.4 Carmat Brain Bionics Revenue (US$ Million) & (2019-2024)
7.12.5 Carmat Recent Developments
7.13 Cleveland Fes Center
7.13.1 Cleveland Fes Center Profile
7.13.2 Cleveland Fes Center Main Business
7.13.3 Cleveland Fes Center Brain Bionics Products, Services and Solutions
7.13.4 Cleveland Fes Center Brain Bionics Revenue (US$ Million) & (2019-2024)
7.13.5 Cleveland Fes Center Recent Developments
7.14 COAPT
7.14.1 COAPT Profile
7.14.2 COAPT Main Business
7.14.3 COAPT Brain Bionics Products, Services and Solutions
7.14.4 COAPT Brain Bionics Revenue (US$ Million) & (2019-2024)
7.14.5 COAPT Recent Developments
7.15 Cochlear
7.15.1 Cochlear Profile
7.15.2 Cochlear Main Business
7.15.3 Cochlear Brain Bionics Products, Services and Solutions
7.15.4 Cochlear Brain Bionics Revenue (US$ Million) & (2019-2024)
7.15.5 Cochlear Recent Developments
7.16 Cyberdyne
7.16.1 Cyberdyne Profile
7.16.2 Cyberdyne Main Business
7.16.3 Cyberdyne Brain Bionics Products, Services and Solutions
7.16.4 Cyberdyne Brain Bionics Revenue (US$ Million) & (2019-2024)
7.16.5 Cyberdyne Recent Developments
8 Industry Chain Analysis
8.1 Brain Bionics Industrial Chain
8.2 Brain Bionics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Brain Bionics Sales Model
8.5.2 Sales Channel
8.5.3 Brain Bionics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Abiomed Inc.
Activelink
Advanced Bionics
Alterg
Axosuits
Bae Systems
Bionx Medical Technologies
B-Temia
Bana Teknoloji
Bionik Laboratories
Bioservo Technologies
Carmat
Cleveland Fes Center
COAPT
Cochlear
Cyberdyne

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.